The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.


Journal article


Nadia Abbass, Raya Nahlawi, Jacqueline K. Shaia, Kevin C. Allan, D. Kaelber, Katherine E. Talcott, Rishi P. Singh
American journal of ophthalmology-glaucoma, 2025

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Abbass, N., Nahlawi, R., Shaia, J. K., Allan, K. C., Kaelber, D., Talcott, K. E., & Singh, R. P. (2025). The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy. American Journal of Ophthalmology-Glaucoma.


Chicago/Turabian   Click to copy
Abbass, Nadia, Raya Nahlawi, Jacqueline K. Shaia, Kevin C. Allan, D. Kaelber, Katherine E. Talcott, and Rishi P. Singh. “The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.” American journal of ophthalmology-glaucoma (2025).


MLA   Click to copy
Abbass, Nadia, et al. “The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.” American Journal of Ophthalmology-Glaucoma, 2025.


BibTeX   Click to copy

@article{nadia2025a,
  title = {The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.},
  year = {2025},
  journal = {American journal of ophthalmology-glaucoma},
  author = {Abbass, Nadia and Nahlawi, Raya and Shaia, Jacqueline K. and Allan, Kevin C. and Kaelber, D. and Talcott, Katherine E. and Singh, Rishi P.}
}


Share
Tools
Translate to